Navigation Links
IRIDEX Introduces Non-Invasive MicroPulse™ Therapy for Glaucoma
Date:4/27/2012

MOUNTAIN VIEW, Calif., April 27, 2012 /PRNewswire/ -- IRIDEX Corporation today announced the launch of a new non-invasive, in-office glaucoma procedure based on its proprietary MicroPulse™ technology.  The new glaucoma therapy, a tissue-sparing, repeatable therapy called MicroPulse Laser Trabeculoplasty (MLT), was introduced by IRIDEX at the recent American Society of Cataract and Refractive Surgery (ASCRS).

Glaucoma is the leading cause of adult irreversible blindness. It is estimated that more than 4 million people in the US and approximately 60 million people worldwide are afflicted with the disease today.

MLT was first introduced by IRIDEX in its infrared laser platforms, but recent technology advancements have now made it available with the IRIDEX green laser system (IQ 532), our most versatile and highest selling laser used by the broadest group of ophthalmologists. The unique ability of the IQ 532 to offer tissue-sparing repeatable therapies for both glaucoma and retinal diseases represents a market breakthrough as well as providing ophthalmologists a very high return on their capital investment, said Dr. Dominik Beck, IRIDEX President and CEO.

David Gossage, M.D., medical director of the Gossage Eye Institute, noted that the addition of the MicroPulse module to the IQ 532 system makes it a valid option for a much broader patient population than has historically been the case.

"Compared to other lasers used for the treatment of glaucoma, the IQ 532 with the MicroPulse module offers greater versatility because it can also be used for a range of other conditions including diabetic macular edema, proliferative diabetic retinopathy, and retinal tears," Dr. Gossage said.  "I'm comfortable offering MLT to glaucoma patients as a first-line option because of its potential to reduce intraocular pressure without causing tissue damage."

MLT produces laser pulses at very short durations to create a therapeutic
'/>"/>

SOURCE IRIDEX Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. IRIDEX to Present at Upcoming Investment Conferences
2. IRIDEX Reports 2011 Fourth Quarter and Year-End Results
3. IRIDEX Announces Fourth Quarter and Full Year 2011 Conference Call and Release Date
4. IRIDEX MicroPulse™ Laser Therapy Enhances Visual Function in Patients with Central Serous Chorioretinopathy (CSC)
5. IRIDEX to Present at the Sidoti & Company New York Micro Cap Conference
6. Cutera and IRIDEX Announce Acquisition of IRIDEX Aesthetic Business Unit
7. 10-Year Study Demonstrates IRIDEX MicroPulse™ Laser Therapy Safe, Effective for Patients with Diabetic Macular Edema
8. IRIDEX Signs License and Distribution Agreement with Leader in Eye Care
9. IRIDEX Reports 2011 Third Quarter and Nine-Month Results
10. IRIDEX Announces Third Quarter 2011 Conference Call and Release Date
11. IRIDEX Launches New MicroPulse™ Module Targeting the Broad Ophthalmology Laser Photocoagulation Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014 Somewhere between ... hearing health was forgotten. But Audicus , a ... hear better this new year. Hearing loss ... the aging population, though it is often unaddressed. Forty-eight ... four has a hearing aid, mainly due to price. ...
(Date:12/19/2014)... Dec. 18, 2014  Decision Resources Group finds that ... States will increase to a value of ... driven by expansion in the large direct energy device ... be increasingly adopted due to the advantages they offer ... key findings from Decision Resources Group,s coverage of the ...
(Date:12/19/2014)... 18, 2014 Baptist Health Lexington is the first ... receive full Atrial Fibrillation with Electrophysiology Services (EPS) Accreditation status ... Atrial fibrillation is the most common cardiac arrhythmia and has ... can lead to stroke and possible death. More than 5 ... have atrial fibrillation and the numbers are rapidly increasing as ...
Breaking Medicine Technology:Audicus Will Help People Resolve to Hear Better in 2015 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 2U.S. Laparoscopic Device Market Will Reach Over $4.3 Billion by 2023 3Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3
... May 11, 2011 Cumberland Pharmaceuticals Inc. ... focused on hospital acute care and gastroenterology markets, today ... the 2011 UBS Global Specialty Pharmaceuticals Conference in London ... The presentation will be simultaneously webcast and ...
... Inc. (OTC Bulletin Board: NEPH ), a ... therapeutic applications, infection control, and water purification, today announced ... from the Therapeutic Products Directorate of Health Canada, the ... Ultrafilters (DSU) in Canada to filter out biological contaminants ...
Cached Medicine Technology:Nephros Receives Approval to Market Dual Stage Ultrafilters in Canada 2Nephros Receives Approval to Market Dual Stage Ultrafilters in Canada 3Nephros Receives Approval to Market Dual Stage Ultrafilters in Canada 4
(Date:12/21/2014)... SCI explores disability in sports ... barriers for disabled athletes with Aaron Scheidies , ... condition called juvenile macular degeneration, where he loses his ... his athletic ambitions to his vision and how he ... pioneer the way for other blind and visually impaired ...
(Date:12/21/2014)... 21, 2014 Concept Plus, LLC. a ... headquartered in Fairfax, VA., today announced it has been ... 50 list, which ranks the fastest growing government contracting small ... to 2013. , This is the first year that Concept ... # 20 with a 95.92% compound annual growth rate. “For ...
(Date:12/20/2014)... 20, 2014 An improving macroeconomic landscape ... benefited the Massage Services industry over the ... industry products, the anticipated 1.0% annualized increase in per ... consumers with the means to afford additional massages. “While ... massage in a given year has declined from 2009 ...
(Date:12/20/2014)... 20, 2014 Recently, VogueQueen.com, a leading ... VogueQueen Big Sale Online for 2015. Great discounts ... new and old consumers can get a discount, up ... the company’s website before January 30, 2015. , VogueQueen.com ... and launched a prom dress promotion. Many customers worldwide ...
(Date:12/20/2014)... The aftermath of the November 24th hack on Sony ... Hollywood, but worldwide. As reported in the Los ... attack are starting a finger-pointing game which could put some ... are not the only ones affected, regular employees who had ... times ahead, agents and lawyers could be in for some ...
Breaking Medicine News(10 mins):Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3Health News:Concept Plus, LLC. Named One of Washington Technology’s Fast 50 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:VogueQueen Big Sale Online For The Coming 2015 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 3Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 4Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 5
... AUGUSTA, Ga. A new strategy that takes advantage of ... extra months of life with few side effects, researchers say., ... a sort of front door by pairing a substance attracted ... be given systemically, said Dr. Sharad Ghamande, Chief of the ...
... BOSTON -- Even yeast understand austerity. A finely tuned system evolved ... times come as fast as they go. The system, a molecular ... protein that turns growth on in times of plenty and shuts ... lab of Wenyi Wei, PhD, an investigator in the Department of ...
... Reporter , THURSDAY, Oct. 27 (HealthDay News) -- Two aspirin a ... half in people who are predisposed to these types of tumors, ... each also cut the risk of other tumors related to Lynch ... to research published in the Oct. 28 online edition of ...
... Reinberg HealthDay Reporter , THURSDAY, Oct. 27 (HealthDay ... part B benefits in 2012 will be less than expected ... U.S. health officials said Thursday. However, for those already ... most people with Medicare have paid a monthly premium of ...
... fourth-generation oncolytic virus designed to both kill cancer cells ... earlier versions when tested in animal models of human ... University Comprehensive Cancer Center Arthur G. James Cancer ... James) are developing the oncolytic virus as a treatment ...
... 27, 2011Bruce Beutler, MD, a co-recipient of the 2011 Nobel ... molecular mechanism that can cause the body to attack itself ... ahead of print in Journal of Interferon & Cytokine ... Inc. ( www.liebertpub.com ) and is available free at ...
Cached Medicine News:Health News:Folate receptors may serve as a front door to ovarian cancer treatment 2Health News:Unraveling the complex signaling that helps cells know when to grow, when to sit tight 2Health News:Unraveling the complex signaling that helps cells know when to grow, when to sit tight 3Health News:Daily Aspirin May Help Prevent Colon Cancer for Those at High Risk 2Health News:Daily Aspirin May Help Prevent Colon Cancer for Those at High Risk 3Health News:Medicare Part B Premium Increase Lower Than Expected 2Health News:New oncolytic virus shows improved effectiveness in preclinical testing 2
... The ESR-10 Manual Rack is ... for determining the erythrocyte sedimentation rate ... minutes using 1.2ml Streck ESR-Vacuum Tubes. ... 10 tubes simultaneously. The ESR-10 Manual ...
... use as a sheath fluid when performing ... of Cytometry Concentrate dilutes to 3L of ... Cubitainers, Streck Cytometry Concentrate reduces heavy lifting, ... compromising performance. Streck Cytometry Concentrate has a ...
... is a stabilized preparation of ... be used as a complete ... positive cells. It is compatible ... gating strategies. CD-Chex CD34 has ...
... A lytic reagent manufactured ... determination of hemoglobin and ... Agent IIIA is manufactured ... the Abbott CELL-DYN® 1700. ...
Medicine Products: